A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Online |
| 言語: | 英語 |
| 出版事項: |
International Association for Dental Research (Nigeria Division)
2019
|
| オンライン･アクセス: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
このレコードへの初めてのコメントを付けませんか!